http://www.raredr.com/casestudies/polycythemia-vera/ruxolitinib-pcv
The Safety and Efficacy of Ruxolitinib in Polycythemia Vera

Srdan Verstovsek, MD, PhD




Srdan Verstovsek, MD, PhD of the MD Anderson Cancer Center in Houston, Texas describes the RESPONSE Study showing the efficacy of ruxolitinib in patients with polycythemia vera refractory to hydroxyurea.
Printer Printing...
$content$